In 80 patients on VA-ECMO meeting weaning criteria, levosimendan vs placebo did not reduce weaning failure (25% vs 25%; OR 1.00). Acute kidney injury at day 30 was more frequent with levosimendan (62.5% vs 38.5%). Recruitment stopped early.
RCTn = 80
Guinot et al. Short- and Long-term Efficacy and Safety of Levosimendan in Veno-arterial Extracorporeal Membrane Oxygenation Weaning: The WEANILEVO Randomized Double-blind Multicenter Trial